Home › Asset managers › Aberdeen › 2023-2024 › Against the board
Two kinds of vote are listed: a board-sponsored proposal Aberdeen voted AGAINST or withheld on, and a shareholder proposal it voted FOR, with the board’s recommendation on it where the filings show one. A FOR vote on a proposal the board supported, or took no position on, is listed and labelled, but it is not a vote against the board. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
Everything Only shareholder proposals it backed
1,441 proposals.
| Company | Meeting | Proposal | Category | On the ballot from | Board recommended | Aberdeen voted | Funds |
|---|---|---|---|---|---|---|---|
| TENET HEALTHCARE CORP. | May 22, 2024 | To approve, on an advisory basis, the Company's executive compensation. | Say-on-Pay | Board | AGAINST | 3 | |
| TERADYNE INC. | May 9, 2024 | To approve, in a non-binding, advisory vote, the compensation of the Company's named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| TETRA TECH INC. | February 29, 2024 | To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for fiscal year 2024. | Audit-related | Board | AGAINST | 3 | |
| TEXTRON INC. | April 24, 2024 | Approval of the advisory (non-binding) resolution to approve executive compensation. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| TRACTOR SUPPLY CO. | May 9, 2024 | To approve, on a non-binding, advisory basis, the compensation of the named executive officers of the Company (Say on Pay) | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| TRANSDIGM GROUP INC. | March 7, 2024 | Approval, on an advisory basis, of the compensation of our named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| TRAVELERS COMPANIES INC. | May 15, 2024 | Non-binding vote to approve executive compensation. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| TREX COMPANY INC. | May 7, 2024 | Non-binding advisory vote on executive compensation ("say-on-pay"). | Say-on-Pay | Board | AGAINST | 3 | |
| TWILIO INC. | June 6, 2024 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| U.S. BANCORP | April 16, 2024 | An advisory vote to approve the compensation of our executives disclosed in the proxy statement. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| UDR INC. | May 23, 2024 | Advisory vote to approve named executive officer compensation. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| ULTRAGENYX PHARMACEUTICAL INC. | June 18, 2024 | Advisory (non-binding) vote to approve the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 3 | |
| ULTRATECH CEMENT LTD. | August 11, 2023 | Reelect Rajashree Birla as Director | Director Elections | Board | AGAINST | 3 | |
| UNITED AIRLINES HOLDINGS INC. | May 22, 2024 | A Vote to Approve, on a Nonbinding Advisory Basis, the Compensation of the Company's Named Executive Officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| UNIVERSAL HEALTH REALTY INCOME TRUST | June 5, 2024 | Advisory (nonbinding) vote to approve named executive officer compensation. | Say-on-Pay | Board | AGAINST | 3 | |
| VERISK ANALYTICS INC. | May 15, 2024 | To approve executive compensation on an advisory, non-binding basis. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| VULCAN MATERIALS CO. | May 10, 2024 | Approval, on an advisory basis, of the compensation of our named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| WALGREENS BOOTS ALLIANCE INC. | January 25, 2024 | Advisory vote to approve named executive officer compensation. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| WARNER BROS. DISCOVERY INC. | June 3, 2024 | To vote on an advisory resolution to approve the 2023 compensation of Warner Bros. Discovery, Inc.'s named executive officers, commonly referred to as a "Say-on-Pay" vote. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| WEC ENERGY GROUP INC. | May 9, 2024 | Advisory vote to approve executive compensation of the named executive officers | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| WELLTOWER INC. | May 23, 2024 | The ratification of the appointment of Ernst & Young LLP as Welltower Inc.'s independent registered public accounting firm for the year ending December 31, 2024. | Audit-related | Board | AGAINST | 3 | |
| WEST PHARMACEUTICAL SERVICES INC. | April 23, 2024 | Election of Directors: Thomas W. Hofmann | Director Elections | Board | AGAINST | 3 | |
| WEST PHARMACEUTICAL SERVICES INC. | April 23, 2024 | Ratification of the appointment of PricewaterhouseCoopers LLP ("PwC") as our independent registered public accounting firm for 2024; and | Audit-related | Board | AGAINST | 3 | |
| WESTERN DIGITAL CORP. | November 15, 2023 | Approval on an advisory basis of the named executive officer compensation disclosed in the Proxy Statement. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| WILLIAMS-SONOMA INC. | May 29, 2024 | An advisory vote to approve executive compensation | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| WILLIS TOWERS WATSON PUBLIC LIMITED CO. | May 22, 2024 | Approve, on an advisory basis, the named executive officer compensation. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| WINTRUST FINANCIAL CORP. | May 23, 2024 | Proposal to approve, on an advisory (non-binding) basis, the Company's executive compensation as described in the 2024 Proxy Statement. | Say-on-Pay | Board | AGAINST | 3 | |
| WYNN RESORTS LTD. | May 2, 2024 | To approve, on a non-binding advisory basis, the compensation of our named executive officers as described in the proxy statement. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| XCEL ENERGY INC. | May 22, 2024 | Approval of Xcel Energy Inc.'s executive compensation in an advisory vote (say on pay vote) | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| XYLEM INC. | May 16, 2024 | Advisory vote to approve the compensation of our named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| YUM! BRANDS INC. | May 16, 2024 | Advisory Vote on Executive Compensation. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| ZAI LAB LTD. | June 18, 2024 | THAT, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement, is hereby approved. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| ZEBRA TECHNOLOGIES CORP. | May 9, 2024 | Advisory vote to approve Named Executive Officers' compensation. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| ZIMMER BIOMET HOLDINGS INC. | May 10, 2024 | Election of Directors: Arthur J. Higgins | Director Elections | Board | AGAINST | 3 | |
| ZIMMER BIOMET HOLDINGS INC. | May 10, 2024 | Election of Directors: Robert A. Hagemann | Director Elections | Board | AGAINST | 3 | |
| ZIMMER BIOMET HOLDINGS INC. | May 10, 2024 | Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2024. | Audit-related | Board | AGAINST | 3 | |
| 89BIO INC. | May 29, 2024 | Election of Directors: To be elected for terms expiring in 2027: Kathleen LaPorte | Director Elections | Board | WITHHOLD | 2 | |
| ADAPTIVE BIOTECHNOLOGIES CORP. | June 7, 2024 | To elect two Class II director nominees to serve on the board of directors of Adaptive Biotechnologies Corporation for a three-year term expiring at the 2027 annual meeting of shareholders: Peter Neupert | Director Elections | Board | WITHHOLD | 2 | |
| ADVANCED DRAINAGE SYSTEMS INC. | July 20, 2023 | Ratification of the appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm for fiscal year 2024. | Audit-related | Board | AGAINST | 2 | |
| AGILENT TECHNOLOGIES INC. | March 14, 2024 | To ratify the Audit and Finance Committee's appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm. | Audit-related | Board | AGAINST | 2 | |
| AKERO THERAPEUTICS INC. | June 7, 2024 | Election of Class II Directors to serve until the 2027 annual meeting of stockholders and until his or her successor has been duly elected and qualified: Seth L. Harrison, M.D. | Director Elections | Board | WITHHOLD | 2 | |
| ALEXANDRIA REAL ESTATE EQUITIES INC. | May 14, 2024 | Election of Directors: James P. Cain | Director Elections | Board | AGAINST | 2 | |
| ALEXANDRIA REAL ESTATE EQUITIES INC. | May 14, 2024 | Election of Directors: Maria C. Freire | Director Elections | Board | AGAINST | 2 | |
| ALEXANDRIA REAL ESTATE EQUITIES INC. | May 14, 2024 | Election of Directors: Michael A. Woronoff | Director Elections | Board | AGAINST | 2 | |
| ALEXANDRIA REAL ESTATE EQUITIES INC. | May 14, 2024 | Election of Directors: Richard H. Klein | Director Elections | Board | AGAINST | 2 | |
| ALEXANDRIA REAL ESTATE EQUITIES INC. | May 14, 2024 | To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accountants for the fiscal year ending December 31, 2024, as more particularly described in the accompanying Proxy Statement. | Audit-related | Board | AGAINST | 2 | |
| ALGONQUIN POWER & UTILITIES CORP. | June 4, 2024 | Advisory Vote on Executive Compensation Approach | Compensation | Board | AGAINST | 2 | |
| ALGONQUIN POWER & UTILITIES CORP. | June 4, 2024 | Amend Share Unit Plan | Compensation | Board | AGAINST | 2 | |
| ALKERMES PLC | May 31, 2024 | To renew Board authority to disapply the statutory pre-emption rights that would otherwise apply under Irish law. | Capital Structure | Board | AGAINST | 2 | |
| ALNYLAM PHARMACEUTICALS INC. | May 16, 2024 | To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as Alnylam's independent auditors for the fiscal year ending December 31, 2024. | Audit-related | Board | AGAINST | 2 | |
| ALPHATEC HOLDINGS INC. | June 12, 2024 | To elect nine persons to our Board of Directors; Mortimer Berkowitz III | Director Elections | Board | WITHHOLD | 2 | |
| ALTAIR ENGINEERING INC. | May 16, 2024 | To vote, on an advisory basis, on the compensation of the Company's named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 2 | |
| ALTIMMUNE INC. | September 28, 2023 | Hold an advisory vote on the compensation of the Company's named executive officers as disclosed in the attached Proxy Statement. | Say-on-Pay | Board (inferred) | AGAINST | 2 | |
| ALX ONCOLOGY HOLDINGS INC. | June 12, 2024 | Advisory vote to approve named executive officer compensation. | Say-on-Pay | Board (inferred) | AGAINST | 2 | |
| AMCOR PLC | November 8, 2023 | To approve, by non-binding, advisory vote, the Company's executive compensation. | Say-on-Pay | Board (inferred) | AGAINST | 2 | |
| AMERICAN ELECTRIC POWER COMPANY INC. | April 23, 2024 | Election of Directors: Linda A. Goodspeed | Director Elections | Board | AGAINST | 2 | |
| AMERICAN WATER WORKS COMPANY INC. | May 15, 2024 | Election of Directors: Martha Clark Goss | Director Elections | Board | AGAINST | 2 | |
| AMERICAN WATER WORKS COMPANY INC. | May 15, 2024 | Ratification of the appointment, by the Audit, Finance and Risk Committee of the Board of Directors, of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for 2024. | Audit-related | Board | AGAINST | 2 | |
| AMICUS THERAPEUTICS INC. | June 6, 2024 | Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. | Audit-related | Board | AGAINST | 2 | |
| APARTMENT INCOME REIT CORP. | September 15, 2023 | Advisory vote on executive compensation (Say on Pay). | Say-on-Pay | Board (inferred) | AGAINST | 2 | |
| APARTMENT INCOME REIT CORP. | June 25, 2024 | Proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to our principal executive officer, principal financial officer, and the three other most highly compensated executive officers calculated in accordance with the Securities and Exchange Commission's rules and regulations, that is based on or otherwise relates to the merger. | Say-on-Pay | Board (inferred) | AGAINST | 2 | |
| APARTMENT INVESTMENT AND MANAGEMENT CO. | September 29, 2023 | To conduct an advisory vote to approve executive compensation. | Say-on-Pay | Board (inferred) | AGAINST | 2 | |
| APARTMENT INVESTMENT AND MANAGEMENT CO. | June 28, 2024 | Advisory vote to approve executive compensation. | Say-on-Pay | Board (inferred) | AGAINST | 2 | |
| ARAMARK | January 30, 2024 | To hold a non-binding advisory vote on executive compensation. | Say-on-Pay | Board (inferred) | AGAINST | 2 | |
| ARCA BIOPHARMA INC. | January 30, 2024 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in this proxy statement. | Say-on-Pay | Board (inferred) | AGAINST | 2 | |
| ARCBEST CORP. | April 26, 2024 | To approve, on an advisory basis, the compensation of the Company's Named Executive Officers. | Say-on-Pay | Board | AGAINST | 2 | |
| ARDELYX INC. | June 14, 2024 | To approve the Amended and Restated 2014 Equity Incentive Award Plan; | Compensation | Board | AGAINST | 2 | |
| ARDELYX INC. | June 14, 2024 | To elect two Class I directors to hold office until the 2027 Annual Meeting of Stockholders and until their successors are elected and qualified: Onaiza Cadoret-Manier | Director Elections | Board | WITHHOLD | 2 | |
| ASCENDIS PHARMA A/S | May 30, 2024 | Approve Warrant Plan for Key Employees | Compensation | Board | AGAINST | 2 | |
| ATLAS COPCO AB | April 24, 2024 | Approve Remuneration Report | Compensation | Board | AGAINST | 2 | |
| ATLAS COPCO AB | April 24, 2024 | Reelect Anna Ohlsson-Leijon as Director | Director Elections | Board | AGAINST | 2 | |
| ATLAS COPCO AB | April 24, 2024 | Reelect Hans Straberg as Board Chair | Director Elections | Board | AGAINST | 2 | |
| ATLAS COPCO AB | April 24, 2024 | Reelect Johan Forssell as Director | Director Elections | Board | AGAINST | 2 | |
| ATLAS COPCO AB | April 24, 2024 | Reelect Peter Wallenberg Jr as Director | Director Elections | Board | AGAINST | 2 | |
| AUTOLIV INC. | May 10, 2024 | Advisory Vote on Autoliv, Inc.'s 2023 Executive Compensation | Say-on-Pay | Board (inferred) | AGAINST | 2 | |
| AVALONBAY COMMUNITIES INC. | May 16, 2024 | To ratify the selection of Ernst & Young LLP as the Company's independent auditors for the year ending December 31, 2024. | Audit-related | Board | AGAINST | 2 | |
| AVANGRID INC. | July 18, 2023 | APPROVE, ON AN ADVISORY BASIS, NAMED EXECUTIVE OFFICER COMPENSATION. | Say-on-Pay | Board (inferred) | AGAINST | 2 | |
| AZEK COMPANY INC. | March 1, 2024 | To approve, on an advisory, non-binding basis, the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 2 | |
| B3 SA-BRASIL, BOLSA, BALCAO | April 25, 2024 | Approve Remuneration of Company's Management | Compensation | Board | ABSTAIN | 2 | |
| BANNER CORP. | May 22, 2024 | Advisory approval of the compensation of Banner Corporation's named executive officers | Say-on-Pay | Board | AGAINST | 2 | |
| BEIGENE LTD. | June 5, 2024 | Ordinary Resolution THAT, on a non-binding, advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement, be and is hereby approved. | Say-on-Pay | Board (inferred) | AGAINST | 2 | |
| BEIGENE LTD. | June 5, 2024 | Resolution 10 - Ordinary Resolution THAT the Company and its underwriters be and are hereby authorized, in their sole discretion, to allocate to Amgen Inc. ("Amgen"), up to a maximum amount of shares in order to maintain the same shareholding percentage of Amgen (based on the then-outstanding share capital of the Company) before and after the allocation of the corresponding securities issued pursuant to an offering conducted pursuant to the general mandate set forth in Resolution 7 for a period of five years, which period will be subject to an extension on a rolling basis each year. | Capital Structure | Board | AGAINST | 2 | |
| BEIGENE LTD. | June 5, 2024 | Resolution 11 - Ordinary Resolution THAT the grant of restricted share units ("RSUs") with a grant date fair value of US$6,000,000 to Mr. John V. Oyler under the Second Amended and Restated 2016 Share Option and Incentive Plan (as amended, the "2016 Plan"), according to the terms and conditions described in the Proxy Statement, be and is hereby approved. | Compensation | Board | AGAINST | 2 | |
| BEIGENE LTD. | June 5, 2024 | Resolution 13 - Ordinary Resolution THAT the grant of RSUs with a grant date fair value of US$1,333,333 to Dr. Xiaodong Wang under the 2016 Plan, according to the terms and conditions described in the Proxy Statement, be and is hereby approved. | Compensation | Board | AGAINST | 2 | |
| BEIGENE LTD. | June 5, 2024 | Resolution 14 - Ordinary Resolution THAT the grant of RSUs with a grant date fair value of US$200,000 to each of the independent non-executive directors, Dr. Olivier Brandicourt, Dr. Margaret Dugan, Mr. Donald W. Glazer, Mr. Michael Goller, Mr. Anthony C. Hooper, Mr. Ranjeev Krishana, Dr. Alessandro Riva, Dr. Corazon (Corsee) D. Sanders, and Mr. Qingqing Yi, under the 2016 Plan, according to the terms and conditions described in the Proxy Statement, be and is hereby approved. | Compensation | Board | AGAINST | 2 | |
| BEIGENE LTD. | June 5, 2024 | Resolution 17(a) - Ordinary Resolution THAT the Third Amended and Restated 2016 Share Option and Incentive Plan of the Company, as described in the Proxy Statement, be and is hereby approved. | Compensation | Board | AGAINST | 2 | |
| BEIGENE LTD. | June 5, 2024 | Resolution 2 - Ordinary Resolution THAT Donald W. Glazer be and is hereby re-elected to serve as a Class II director of the Company until the 2027 annual general meeting of shareholders and until his successor is duly elected and qualified, subject to his earlier resignation or removal. | Director Elections | Board | AGAINST | 2 | |
| BEIGENE LTD. | June 5, 2024 | Resolution 7 - Ordinary Resolution THAT the granting of a share issue mandate to the Board of Directors to issue, allot or deal with unissued ordinary shares and/or American Depositary Shares ("ADSs") (including any sale or transfer of treasury shares (which shall have the meaning ascribed to it under the HK Listing Rules coming into effect on June 11, 2024) out of treasury) not exceeding 20% of the total number of issued shares of the Company (excluding treasury shares) as of the date of passing of this ordinary resolution up to the next annual general meeting of shareholders of the Company be and is hereby approved. | Capital Structure | Board | AGAINST | 2 | |
| BEIGENE LTD. | June 5, 2024 | Resolution 9 - Ordinary Resolution THAT the Company and its underwriters be and are hereby authorized, in their sole discretion, to allocate to each of Baker Bros. Advisors LP and Hillhouse Capital Management, Ltd. and parties affiliated with each of them (the "Existing Shareholders"), up to a maximum amount of shares in order to maintain the same shareholding percentage of each of the Existing Shareholders (based on the then-outstanding share capital of the Company) before and after the allocation of the corresponding securities issued pursuant to an offering conducted pursuant to the general mandate set forth in Resolution 7 for a period of five years, which period will be subject to an extension on a rolling basis each year. | Capital Structure | Board | AGAINST | 2 | |
| BILL HOLDINGS INC. | December 7, 2023 | To approve, on an advisory basis, the compensation of our Named Executive Officers (Say-on-Pay). | Say-on-Pay | Board (inferred) | AGAINST | 2 | |
| BIOMARIN PHARMACEUTICAL INC. | May 21, 2024 | Election of Directors: Elaine J. Heron | Director Elections | Board | WITHHOLD | 2 | |
| BIOMARIN PHARMACEUTICAL INC. | May 21, 2024 | Election of Directors: Richard A. Meier | Director Elections | Board | WITHHOLD | 2 | |
| BIOMARIN PHARMACEUTICAL INC. | May 21, 2024 | To ratify the selection of KPMG LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2024. | Audit-related | Board | AGAINST | 2 | |
| BIONTECH SE | May 17, 2024 | Approve Issuance of Warrants/Bonds with Warrants Attached/Convertible Bonds without Preemptive Rights up to Aggregate Nominal Amount of EUR 3 Billion; Approve Creation of EUR 24.9 Million Pool of Capital to Guarantee Conversion Rights | Capital Structure | Board | AGAINST | 2 | |
| BIONTECH SE | May 17, 2024 | Approve Remuneration Policy for the Management Board | Compensation | Board | AGAINST | 2 | |
| BIONTECH SE | May 17, 2024 | Approve Remuneration Policy for the Supervisory Board | Compensation | Board | AGAINST | 2 | |
| BIONTECH SE | May 17, 2024 | Approve Remuneration Report | Compensation | Board | AGAINST | 2 | |
| BOSTON PROPERTIES INC. | May 22, 2024 | Election of Directors: Carol B. Einiger | Director Elections | Board | AGAINST | 2 | |
| BOSTON PROPERTIES INC. | May 22, 2024 | To ratify the Audit Committee's appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. | Audit-related | Board | AGAINST | 2 | |
| BRIDGEBIO PHARMA INC. | June 21, 2024 | To approve an amendment and restatement of the 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan to, among other things, increase the number of shares of common stock reserved for issuance thereunder by 6,500,000 shares. | Compensation | Board | AGAINST | 2 |
← Previous Page 8 of 15 Next →
← Back to Aberdeen 2023-2024 overview
Built November 1, 2026 from SEC Form N-PX filings.